CardioGenics Holdings Inc

OTCPK:CGNH Stock Report

Market Cap: US$14.3k

CardioGenics Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yahia Gawad

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure28.1yrs
CEO ownershipn/a
Management average tenure24.1yrs
Board average tenure15.4yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Yahia Gawad (66 yo)

28.1yrs

Tenure

US$119,449

Compensation

Dr. Yahia Abdul Gawad, MB, Ch B., MD, MSc. has been Chief Executive Officer of CardioGenics Holdings Inc. (formerly, JAG Media Holdings Inc.) since 1997 and its Director since 1997. Dr. Gawad is the Founde...

Leadership Team

NamePositionTenureCompensationOwnership
Yahia Gawad
Founder28.1yrsUS$119.45kno data
James Essex
Chief Financial Officer24.1yrsUS$28.67kno data
Linda Sterling
Corporate Secretary & Director22.1yrsno datano data

24.1yrs

Average Tenure

66yo

Average Age

Experienced Management: CGNH's management team is seasoned and experienced (24.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yahia Gawad
Founder28.1yrsUS$119.45kno data
Linda Sterling
Corporate Secretary & Director16.1yrsno datano data
Julian Tabatznik
Acting Chairman20.1yrsno datano data
Robert Roberts
Member of Scientific Advisory Board14.7yrsno datano data
William Kostuk
Member of Clinical Advisory Board14.7yrsno datano data
Karim Murabet
Independent Director10.1yrsno datano data

15.4yrs

Average Tenure

66yo

Average Age

Experienced Board: CGNH's board of directors are seasoned and experienced ( 15.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/14 08:29
End of Day Share Price 2024/12/19 00:00
Earnings2016/01/31
Annual Earnings2015/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CardioGenics Holdings Inc is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian MarckxZacks Investment Research Inc.